✦ LIBER ✦

Cross-species absorption, metabolism, distribution and pharmacokinetics of BI 201335, a potent HCV genotype 1 NS3/4A protease inhibitor

✍ Scribed by Duan, Jianmin; Yong, Chan-Loi; Garneau, Michel; Amad, Ma’an; Bolger, Gordon; De Marte, Josie; Montpetit, Hélène; Otis, Francois; Jutras, Martin; Rhéaume, Manon

Book ID: 115486625
Publisher: Informa plc
Year: 2011
Tongue: English
Weight: 771 KB
Volume: 42
Category: Article
ISSN: 0049-8254
DOI: 10.3109/00498254.2011.611546

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Potency, safety, and pharmacokinetics of

Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection

✍ Michael P. Manns; Marc Bourlière; Yves Benhamou; Stanislas Pol; Maurizio Bonacin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 767 KB

954 BI 201335, A POTENT HCV NS3 PROTEASE

954 BI 201335, A POTENT HCV NS3 PROTEASE INHIBITOR, IN TREATMENT-NAIVE AND -EXPERIENCED CHRONIC HCV GENOTYPE-1 INFECTION: GENOTYPIC AND PHENOTYPIC ANALYSIS OF THE NS3 PROTEASE DOMAIN

✍ G. Kukolj; Y. Benhamou; M.P. Manns; M. Bourlière; S. Pol; M. Schuchmann; M. Cart 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Bound Structure and Biochemical Mechanis

Bound Structure and Biochemical Mechanism of Action of BI 201335, a Potent, Non-covalent Inhibitor of HCV NS3-NS4A Protease

✍ Christopher T. Lemke; Songping Zhao; Nathalie Goudreau; Oliver Hucke; Diane Thib 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Characterization of vaniprevir, a hepati

Characterization of vaniprevir, a hepatitis C virus NS3/4A protease inhibitor, in patients with HCV genotype 1 infection: Safety, antiviral activity, resistance, and pharmacokinetics

✍ Lawitz, Eric; Sulkowski, Mark; Jacobson, Ira; Kraft, Walter K.; Maliakkal, Bened 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 367 KB

753 IMPACT OF LOW DOSE RITONAVIR BOOSTIN

753 IMPACT OF LOW DOSE RITONAVIR BOOSTING ON THE PHARMACOKINETICS OF RG7227 (ITMN-191), A HIGHLY POTENT AND SELECTIVE INHIBITOR OF THE HCV NS3/4A PROTEASE

✍ J.Ö. Haznedar; J. Fretland; G. Leong; S. Blotner; T. Hill; P. Smith; J.Q. Tran 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB